TRYPTYR
Jun 06, 2025
Upcoming Contenders in Dry Eye Disease Drug Space: 5 Therapies to Watch Post-TRYPTYR Approval
The recent approval of the dry eye disease drug TRYPTYR has heightened competition among pharmaceutical companies. Six years after spinning off from Novartis and going public, eye care company Alcon has secured its first FDA approval for a prescription medication targeting dry eye disease. The dry eye dise...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
